ニュース
1 日on MSN
Serena Williams reveals she uses GLP-1 weight loss drug Zepbound: 'I just could never get ...
Serena Williams is opening up about her fitness journey, revealing that she has lost 31 pounds using the injectable GLP-1 ...
Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...
Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss drug.
But what is important to me is transparency.” That calling has led her to this very moment: Williams is ready to share that ...
14 時間
InStyle on MSNSerena Williams Reveals the Real Reason Why She Used GLP-1 Medication to Lose Weight
Serena Williams sat down with the hosts of Today for a candid interview about her use of GLP-1 medication. The Olympic ...
14 時間
21Ninety on MSNSerena Williams Opens Up About GLP-1 Weight Loss, Here’s What Women Should Know
Tennis legend Serena Williams has revealed that she’s lost 31 pounds over the last eight months using a GLP-1 medication.
GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...
Employers are about to spend a lot more on health insurance next year as they shoulder higher costs driven by GLP-1 drugs, ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
1 日
MedPage Today on MSNGood News on GLP-1s and Cancer Risk, With One Exception
GLP-1 agonist users had a 17% lower cancer risk compared to non-users in a large retrospective study. The reductions achieved ...
2 日
24/7 Wall St. on MSNEli Lilly Ranks Among Top Large-Cap Performers as GLP-1 Drug Sales Exceed Billions
Eli Lilly is one of the top growing stocks at the moment. Learn the reasons why this might be a stock to consider.
Some studies have linked the popular weight-loss drugs with a potentially higher risk of eye problems and vision loss. Should ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する